Stay updated on HERV-W Antagonist GNbAC1 Clinical Trial
Sign up to get notified when there's something new on the HERV-W Antagonist GNbAC1 Clinical Trial page.

Latest updates to the HERV-W Antagonist GNbAC1 Clinical Trial page
- ChecktodayChange DetectedA site-wide banner announces that NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check7 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check14 days agoChange DetectedThe site footer revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check35 days agoChange DetectedThe page now shows a 403 Forbidden error with the site's header and navigation intact. Substantive trial metadata and related terms have been removed, making the study information inaccessible on this record.SummaryDifference16%

- Check56 days agoChange DetectedA funding line '2015 ( U.S. NIH Grant/Contract )' was added to the study record, and the revision history was updated to 'Revision: v3.6.6' (replacing v3.6.5).SummaryDifference0.1%

- Check77 days agoChange DetectedThe site revision has been updated to v3.6.5, replacing the previous v3.6.4, indicating a routine update with no visible changes to the study details.SummaryDifference0.1%

Stay in the know with updates to HERV-W Antagonist GNbAC1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HERV-W Antagonist GNbAC1 Clinical Trial page.